The TNF-related apoptosis ligand (TRAIL, Apo2L, TNFSF10, 43 CD253), a TNF-α family member (Wiley et al., 1995) , is an 44 apoptotic ligand that induces cell death by binding to its two 45 death receptors DR4 (TRAIL-R1, TNFRSF10A) and DR5 46 Apo2, TNFRSF10B, Trick2, TRANCE-R, CD262) (Sheridan et al., 1997; Wu et al., 1997) . The two biologically active forms of 48 TRAIL, membrane-bound (mTRAIL) and soluble TRAIL (sTRAIL), 49 are regulated by type I interferon (Sato et al., 2001; Ehrlich et al., 50 2003; Tecchio et al., 2004) . mTRAIL is expressed by leukocytes, 51 including T lymphocytes (Kayagaki et al., 1999) , natural killer 52 cells (Smyth et al., 2001 ), dendritic cells (Vidalain et al., 2000) , B 53 cells, monocytes (Ehrlich et al., 2003) and macrophages 54 (Herbeuval et al., 2003) . TRAIL had been extensively studied in infection (Gasper-Smith et al., 2008) . TRAIL is expressed in 70 lymphoid tissues of both HIV-1 infected individuals 71 (Herbeuval et al., 2006) and SIV-infected macaques 72 (Herbeuval et al., 2009 Nucleus was stained using DAPI (Molecular Probes, Paisley, UK). showed that CD4 and/or Vybrant (red) was homogeneously 334 expressed and precisely delineated T cell membrane ( Fig. 2A) .
335
Overlay pictures also showed the very thin space between the 336 nucleus (DAPI) and the membrane. Right panels showed CD4 337 and Vybrant using bright light. 
stacks are then put together to get a 3D image. (Fig. 2D) . We could observe the membrane in red, and the 360 nucleus in blue, as observed in Fig. 2C Fig. 1D were performed using bright light (Fig. 3A) .
375
Cells were stained with anti-TRAIL antibodies (green) and 376 DAPI. One cell from each condition was selected (Fig. 3B) 
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